JUN 03, 2016 08:17 AM PDT

Phage therapy for C. difficile?

WRITTEN BY: Kerry Evans
Clostridium difficile loves to infect the gut, and these infections (CDIs) can be nasty and difficult to treat. These spore-forming bacteria are often resistant to antibiotics and grow within a protective pseudomembrane in the gut where they cause diarrhea and colitis.

University of Leicester researchers recently reported on the successful use of a bacteriophage cocktail to treat CDI. This technique, often called “phage therapy”, uses bacteriophages to infect and kill pathogenic bacteria without harming the human host.
 
Phage therapy could be used to treat CDIs.
(Side note.) The idea of phage therapy has been around for quite some time. Bacteriophages were first described in the early 1900s, and the Eliava Institute opened in Georgia (the country) in 1923 to research phage therapy. In fact, phage therapy is widely used in a number of European countries, but it has not caught on in the US.

(Back to your regularly scheduled programming.) The University of Leicester group tested various phages for their ability to kill (lyse) C. difficile in vitro. The phages lysed 86% of the clinical C. difficile strains tested. Specifically, the phages were effective against 12 of the 13 most common strains found in the UK.

Then they tested their phage cocktails - mixtures of phages in various combinations - in a hamster model of CDI. They found that certain cocktails reduced the bacterial load in the intestinal lumen by 4 logs and in intestinal tissues by 2 logs.

This is great, except that most of the hamsters still had relatively large amounts of the bacteria in their guts even after phage treatment. The point is, yes, the phage cocktails definitely reduced the overall bacterial burden, but they did not “cure” the animals of the infection.

Essentially, phage therapy bought the animals a bit more time. The animals were sacrificed once they reached a predetermined experimental endpoint (once their body temperature dropped to a certain point, for example). For untreated animals, this was after about 60 hours. However, animals treated with the phage cocktail took about twice as long to reach the same endpoint.

Phage therapy isn’t a cure-all (at least not for CDI). But, it could put a chink in C. difficile’s armor, helping clinicians combat these potentially deadly infections. According to M. Scott Salka, CEO of AmpliPhi Biociences (the company that funded this study), “the prevalence of C. difficile, the high costs of infection control, and the challenge of finding alternative treatments all contribute to the significant clinical and financial burden that CDI imposes on healthcare systems. The positive outcomes of these studies validate phage-based therapy as a promising approach that has the potential to address the growing challenge of CDI.”

Sources: Antimicrobial Agents and Chemotherapy, MedicalXpress, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 13, 2019
Health & Medicine
OCT 13, 2019
Emerging Arbovirus Infections in the Americas
Arboviruses are arthropod-borne pathogens with more than 130 strains known to cause human infections. The majority of these strains belong to three genera:...
OCT 13, 2019
Microbiology
OCT 13, 2019
Specific Gut Microbes Slow ALS Progression in a Mouse Model
We've come a long way in the five years since the ice bucket challenge drew attention to amyotrophic lateral sclerosis (ALS)....
OCT 13, 2019
Immunology
OCT 13, 2019
How to Kill Superbugs
https://www.technologynetworks.com/immunology/news/enhancing-the-infection-fighting-potential-of-natural-products-321553...
OCT 13, 2019
Neuroscience
OCT 13, 2019
Lab-grown mini brains make humanlike 'brain waves'
When a fetus reaches six months old, it starts to produce electrical signals resembling brain waves. Now, we know that clusters of lab-grown human brain ce...
OCT 13, 2019
Health & Medicine
OCT 13, 2019
Acute Flaccid Myelitis and Its Association With Enterovirus D68
Acute flaccid myelitis (AFM), a polio-like infection, caught the attention of physicians in the U.S. during late summer and early fall in 2014. The outbrea...
OCT 13, 2019
Neuroscience
OCT 13, 2019
Alzheimer's to be Diagnosed from Pupil Dilation
Researchers from the University of California have found a low-cost, non-invasive method to aid in diagnosing Alzheimer’s Disease (AD) before cogniti...
Loading Comments...